Experimental validation of peptide immunohistochemistry controls

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 3, 2009, Pages 239-246

  Bogen, Steven A ^a,b   Vani, Kodela ^a   McGraw, Brian ^f   Federico, Vin ^f   Habib, Iqbal ^c   Zeheb, Ron ^d   Luther, Ed ^e   Tristram, Colin ^f   Sompuram, Seshi R ^a,b  

^a Medical Discovery Partners LLC   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Genetix Corporation   (United Kingdom)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e Compucyte Corporation ^*  (United States)

^f Leica Biosystems ^*

Author keywords

Controls; HER 2; Immunohistochemistry; Peptide; Quality control; Standardization

Indexed keywords

FORMALDEHYDE; PEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE;

ANTIGEN RETRIEVAL; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; STAINING; BREAST TUMOR; IMMUNOLOGY; INSTRUMENTATION; STANDARD; TUMOR CELL LINE; VALIDATION STUDY;

BREAST NEOPLASMS; CELL LINE, TUMOR; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDES; QUALITY CONTROL; RECEPTOR, ERBB-2; REFERENCE STANDARDS; SOFTWARE; STAINING AND LABELING;

EID: 66549107830     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181904379     Document Type: Article

References (23)

1. Paik S, Bryant J, Tan-Chiu E, et al. Real-world performance of HER2 testing-National Surgical Adjuvant Breast and Bowel Project experience. J Natl Cancer Inst. 2002;94:852-854. (Pubitemid 34705057)
2. Perez E, Suman V, Davidson N, et al. HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 Intergroup adjuvant trial. J Clin Oncol. 2006;24:3032-3038. (Pubitemid 46638937)
3. Roche P, Suman V, Jenkins R, et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst. 2002;94:855-857. (Pubitemid 34705058)
4. Wolff A, Hammond M, Schwartz J, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for Human Epidermal Growth Factor Receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131: 18-43. (Pubitemid 46174133)
5. Chung G, Zerkowski M, Ghosh S, et al. Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest. 2007; 87:662-669. (Pubitemid 46920099)
6. Moeder C, Giltnane J, Harigopal M, et al. Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome. J Clin Oncol. 2007;25: 5418-5425. (Pubitemid 350232218)
7. Rhodes A, Jasani B, Balaton A, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe: documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Anat Pathol. 2001;115: 44-58.
8. Ross J, Symmans W, Pusztai L, et al. Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes. Clin Can Res. 2007;13:2831-2835.
9. D'Andrea M, Gasparini G. The future of anti-EGFR therapy. Int J Biol Markers. 2007;22(suppl 4):S88-S93.
10. Dei Tos A, Ellis I. Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods? [Review]. Eur J Cancer. 2005;41:1383-1392. (Pubitemid 40826461)
11. Eberhard D, Giaccone G, Johnson B. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-small-cell Lung Cancer Working Group: standardization for use in the Clinical Trial Setting. J Clin Oncol. 2008;26:983-994.
12. Vani K, Sompuram S, Fitzgibbons P, et al. National HER2 proficiency test results using standardized quantitative controls: characterization of laboratory failures. Arch Pathol Lab Med. 2008; 132:211-216. (Pubitemid 351213789)
13. Sompuram S, Kodela V, Ramanathan H, et al. Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality control targets. Clin Chem. 2002; 48:410-420. (Pubitemid 34174574)
14. Sompuram S, Kodela V, Zhang K, et al. A novel quality control slide for quantitative immunohistochemistry testing. J Histochem Cytochem. 2002;50:1425-1434. (Pubitemid 36024889)
15. Sompuram S, Vani K, Bogen S. A molecular model of antigen retrieval using a peptide array. Am J Clin Pathol. 2006;125:91-98. (Pubitemid 43089730)
16. Sompuram S, Vani K, Hafer L, et al. Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes. Am J Clin Pathol. 2006;125:82-90. (Pubitemid 43089729)
17. Sompuram S, McMahon D, Vani K, et al. A novel microscope slide adhesive for poorly adherent tissue sections. J Histotechnol. 2003;26:1-7. (Pubitemid 36792741)
18. Sompuram S, Vani K, Messana E, et al. A molecular mechanism of formalin-fixation and antigen retrieval. Am J Clin Pathol. 2004;121: 190-199. (Pubitemid 38140122)
19. Sompuram S, Vani K, Wei L, et al. A water-stable protected isocyanate glass array substrate. Anal Biochem. 2004;326:55-68. (Pubitemid 38177483)
20. Luther E, Kamentsky L, Henriksen M, et al. Next-generation laser scanning cytometry. Methods Cell Biol. 2004;75:185-218.
21. Hammond M, Barker P, Taube S, et al. Standard reference material for Her2 testing: Report of a National Institute of Standards and Technology-sponsored consensus workshop. Appl Immunohistochem Mol Morphol. 2003;11:103-106. (Pubitemid 36749559)
22. Rhodes A, Jasani B, Couturier J, et al. A formalin-fixed, paraffinprocessed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. Am J Clin Pathol. 2002;117:81-89. (Pubitemid 34052476)
23. Westgard J, Barry P, Hunt M, et al. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981;27:493-501.